EC Number | Application | Comment | Organism |
---|---|---|---|
1.15.1.1 | drug development | the enzyme is a target for development of antiangiogenic and antitumour drugs | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.15.1.1 | tetrathiomolybdate | i.e. ATN-224, choline salt, inhibition leads to antiangiogenic and antitumour effects | Mus musculus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.15.1.1 | O2.- + H+ | Mus musculus | enzyme inhibition by tetrathiomolybdate leads to antiangiogenic and antitumour effects in mice | O2 + H2O2 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.15.1.1 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.15.1.1 | erythrocyte | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.15.1.1 | O2.- + H+ | - |
Mus musculus | O2 + H2O2 | - |
? | |
1.15.1.1 | O2.- + H+ | enzyme inhibition by tetrathiomolybdate leads to antiangiogenic and antitumour effects in mice | Mus musculus | O2 + H2O2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.15.1.1 | CuZn superoxide dismutase 1 | - |
Mus musculus |
1.15.1.1 | SOD1 | - |
Mus musculus |
1.15.1.1 | superoxide dismutase 1 | - |
Mus musculus |